Replacing Pseudoephedrine Easier Said Than Done, OTC Firms Find
This article was originally published in The Tan Sheet
Executive Summary
Reformulating pseudoephedrine products has posed a greater challenge than expected for a number of firms, as passage of a federal bill restricting sale of the ingredient looms
You may also be interested in...
Perrigo’s New Papa: CEO Brings Product Development Know-How To Post
Joseph Papa brings 30 years of experience in healthcare and specialty generic pharmaceutical industries to his new position as president and CEO of Perrigo, the private-label manufacturer announced Sept. 11
Oral Phenylephrine An “Ineffective” Replacement For PSE – Pharmacists
Phenylephrine taken at the FDA-approved dose of 10 mg is "unlikely to provide relief of nasal congestion" and is less efficacious than pseudoephedrine, according to a letter to the editor in the July Journal of Allergy & Clinical Immunology.
Sine-Off Claims To Fight Cough, Cold, Flu – And Meth Abuse
Ads for reformulated Sine-Off cold and sinus products are scripted to position the brand as an active contributor to the nation's fight against methamphetamine abuse